MediXall Group (MediXall Group) Debt-to-EBITDA

: -0.48 (As of Dec. 2022)

View and export this data going back to . Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

MediXall Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $2.63 Mil. MediXall Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.19 Mil. MediXall Group's annualized EBITDA for the quarter that ended in Dec. 2022 was $-5.91 Mil. MediXall Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2022 was -0.48.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for MediXall Group's Debt-to-EBITDA or its related term are showing as below:

MDXL's Debt-to-EBITDA is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 2.57
* Ranked among companies with meaningful Debt-to-EBITDA only.

MediXall Group Debt-to-EBITDA Historical Data

The historical data trend for MediXall Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediXall Group Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.03

-0.04

-0.05

-0.43

MediXall Group Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.04	-0.08	-0.26	-0.53	-0.48

Competitive Comparison

For the Health Information Services subindustry, MediXall Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediXall Group Debt-to-EBITDA Distribution

For the Healthcare Providers & Services industry and Healthcare sector, MediXall Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MediXall Group's Debt-to-EBITDA falls into.

MediXall Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

MediXall Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(2.631	+	0.189)	/	-6.524
	=	-0.43

MediXall Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(2.631	+	0.189)	/	-5.908
	=	-0.48

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2022) EBITDA data.

MediXall Group (OTCPK:MDXL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

MediXall Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MediXall Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

MediXall Group (MediXall Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediXall Group Inc (OTCPK:MDXL) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

2929 East Commercial Boulevard, Suite Ph-D, Fort Lauderdale, FL, USA, 33308

Website

https://www.medixallgroup.com

MediXall Group Inc is an innovation-driven technology company designed to deliver health and well-being services which address gaps in access to care, spiraling healthcare costs, and the pain points faced by both consumers and businesses. It has developed a cloud-based electronic marketplace where clients can shop for medical services; diagnostic procedures and services; and medical equipment and devices. The company's platform connects physicians and service providers to patients, and payers to the physicians and service providers, across all healthcare settings. The company generates revenue from employer customers and consumer subscription fees.